Attenuated Vaccines MarketThe global attenuated vaccines market is set for significant expansion, with sales projected to ...

This is a valuable study on the efficacy of a live-attenuated vaccine that was tested in different animal models and the evidence is convincing. The study has been strengthened after revisions.

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Texas health officials now report 48 cases of measles, mostly among unvaccinated children. Thirteen of the people have been ...

Given the high morbidity and mortality from respiratory syncytial virus (RSV) among HIV-exposed uninfected pediatric patients during early childhood, live-attenuated RSV vaccine candidates should be ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

In the second half of 2021, a highly pathogenic case occurred in a mixed chicken and duck family farm in Guangdong, China. After the duck flocks were immunized with live attenuated duck enteritis ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

The Central Drug Standards Control Organization (CDSCO) has granted approval to Biolumpivaxin, India's first vaccine against ...

A less-virulent poliovirus generated by altering codon usage suggests a new strategy for vaccine development. Figure 1: Development of an attenuated vaccine by two classical methods and the ...

Biovet, part of Bharat Biotech, received CDSCO approval for BIOLUMPIVAXIN, a novel LSD vaccine for dairy cattle and buffaloes ...